RecruitingNot ApplicableNCT06136572

Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

350 participants

Start Date

May 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Rathus Assertiveness scale for people with tourette syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTRathus Assertiveness scale

Questionnaire completion


Locations(1)

CHU Clermont-Ferrand

Clermont-Ferrand, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06136572


Related Trials